Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 237

1.

Testosterone Therapy: An Assessment of the Clinical Consequences of Changes in Hematocrit and Blood Flow Characteristics.

König CS, Balabani S, Hackett GI, Strange RC, Ramachandran S.

Sex Med Rev. 2019 Mar 26. pii: S2050-0521(19)30009-5. doi: 10.1016/j.sxmr.2019.01.003. [Epub ahead of print] Review.

PMID:
30926458
2.

Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors.

Hackett G, Cole N, Mulay A, Strange RC, Ramachandran S.

BJU Int. 2019 Mar;123(3):519-529. doi: 10.1111/bju.14536. Epub 2018 Oct 16.

PMID:
30216622
3.

Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile Function.

Hackett G, Cole N, Mulay A, Strange RC, Ramachandran S.

World J Mens Health. 2018 Sep 12. doi: 10.5534/wjmh.180052M. [Epub ahead of print]

4.

The association of sex hormone-binding globulin with mortality is mediated by age and testosterone in men with type 2 diabetes.

Ramachandran S, Strange RC, Fryer AA, Saad F, Hackett GI.

Andrology. 2018 Nov;6(6):846-853. doi: 10.1111/andr.12520. Epub 2018 Jul 13.

PMID:
30006962
5.

Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.

Hackett G, Cole N, Saghir A, Jones P, Strange RC, Ramachandran S.

Andrology. 2017 Sep;5(5):905-913. doi: 10.1111/andr.12399. Epub 2017 Aug 3.

6.

Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes.

Hackett G, Jones PW, Strange RC, Ramachandran S.

World J Diabetes. 2017 Mar 15;8(3):104-111. doi: 10.4239/wjd.v8.i3.104.

7.

Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.

Hackett G, Cole N, Saghir A, Jones P, Strange RC, Ramachandran S.

BJU Int. 2016 Nov;118(5):804-813. doi: 10.1111/bju.13516. Epub 2016 May 27.

8.

A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels.

Groves C, Shetty C, Strange RC, Waldron J, Ramachandran S.

Postgrad Med J. 2017 Apr;93(1098):205-208. doi: 10.1136/postgradmedj-2016-134062. Epub 2016 Aug 16.

PMID:
27531965
9.

Use of fibrates in the metabolic syndrome: A review.

Shipman KE, Strange RC, Ramachandran S.

World J Diabetes. 2016 Mar 10;7(5):74-88. doi: 10.4239/wjd.v7.i5.74. Review.

10.

Serum testosterone, testosterone replacement therapy and all-cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statins.

Hackett G, Heald AH, Sinclair A, Jones PW, Strange RC, Ramachandran S.

Int J Clin Pract. 2016 Mar;70(3):244-53. doi: 10.1111/ijcp.12779. Epub 2016 Feb 24.

PMID:
26916621
11.

Associations between onset age and disability in multiple sclerosis patients studied using MSSS and a progression model.

Ramachandran S, Strange RC, Jones PW, Kalra S, Nayak D, Hawkins CP.

Mult Scler Relat Disord. 2014 Sep;3(5):593-9. doi: 10.1016/j.msard.2014.06.002. Epub 2014 Jun 24.

PMID:
26265271
12.

Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome.

Strange RC, Shipman KE, Ramachandran S.

World J Diabetes. 2015 Jul 10;6(7):896-911. doi: 10.4239/wjd.v6.i7.896. Review.

13.

A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis.

Mechelli R, Umeton R, Policano C, Annibali V, Coarelli G, Ricigliano VA, Vittori D, Fornasiero A, Buscarinu MC; International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium,2, Romano S, Salvetti M, Ristori G.

PLoS One. 2013 May 16;8(5):e63300. doi: 10.1371/journal.pone.0063300. Print 2013.

14.

Progression of disability in multiple sclerosis: A study of factors influencing median time to reach an EDSS value.

Ramachandran S, Strange RC, Kalra S, Nayak D, Zeegers MP, Gilford J, Hawkins CP.

Mult Scler Relat Disord. 2013 Apr;2(2):109-16. doi: 10.1016/j.msard.2012.09.004. Epub 2012 Oct 24.

PMID:
25877632
15.

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, D'alfonso S, Blackburn H, Martinelli Boneschi F, Liddle J, Harbo HF, Perez ML, Spurkland A, Waller MJ, Mycko MP, Ricketts M, Comabella M, Hammond N, Kockum I, McCann OT, Ban M, Whittaker P, Kemppinen A, Weston P, Hawkins C, Widaa S, Zajicek J, Dronov S, Robertson N, Bumpstead SJ, Barcellos LF, Ravindrarajah R, Abraham R, Alfredsson L, Ardlie K, Aubin C, Baker A, Baker K, Baranzini SE, Bergamaschi L, Bergamaschi R, Bernstein A, Berthele A, Boggild M, Bradfield JP, Brassat D, Broadley SA, Buck D, Butzkueven H, Capra R, Carroll WM, Cavalla P, Celius EG, Cepok S, Chiavacci R, Clerget-Darpoux F, Clysters K, Comi G, Cossburn M, Cournu-Rebeix I, Cox MB, Cozen W, Cree BA, Cross AH, Cusi D, Daly MJ, Davis E, de Bakker PI, Debouverie M, D'hooghe MB, Dixon K, Dobosi R, Dubois B, Ellinghaus D, Elovaara I, Esposito F, Fontenille C, Foote S, Franke A, Galimberti D, Ghezzi A, Glessner J, Gomez R, Gout O, Graham C, Grant SF, Guerini FR, Hakonarson H, Hall P, Hamsten A, Hartung HP, Heard RN, Heath S, Hobart J, Hoshi M, Infante-Duarte C, Ingram G, Ingram W, Islam T, Jagodic M, Kabesch M, Kermode AG, Kilpatrick TJ, Kim C, Klopp N, Koivisto K, Larsson M, Lathrop M, Lechner-Scott JS, Leone MA, Leppä V, Liljedahl U, Bomfim IL, Lincoln RR, Link J, Liu J, Lorentzen AR, Lupoli S, Macciardi F, Mack T, Marriott M, Martinelli V, Mason D, McCauley JL, Mentch F, Mero IL, Mihalova T, Montalban X, Mottershead J, Myhr KM, Naldi P, Ollier W, Page A, Palotie A, Pelletier J, Piccio L, Pickersgill T, Piehl F, Pobywajlo S, Quach HL, Ramsay PP, Reunanen M, Reynolds R, Rioux JD, Rodegher M, Roesner S, Rubio JP, Rückert IM, Salvetti M, Salvi E, Santaniello A, Schaefer CA, Schreiber S, Schulze C, Scott RJ, Sellebjerg F, Selmaj KW, Sexton D, Shen L, Simms-Acuna B, Skidmore S, Sleiman PM, Smestad C, Sørensen PS, Søndergaard HB, Stankovich J, Strange RC, Sulonen AM, Sundqvist E, Syvänen AC, Taddeo F, Taylor B, Blackwell JM, Tienari P, Bramon E, Tourbah A, Brown MA, Tronczynska E, Casas JP, Tubridy N, Corvin A, Vickery J, Jankowski J, Villoslada P, Markus HS, Wang K, Mathew CG, Wason J, Palmer CN, Wichmann HE, Plomin R, Willoughby E, Rautanen A, Winkelmann J, Wittig M, Trembath RC, Yaouanq J, Viswanathan AC, Zhang H, Wood NW, Zuvich R, Deloukas P, Langford C, Duncanson A, Oksenberg JR, Pericak-Vance MA, Haines JL, Olsson T, Hillert J, Ivinson AJ, De Jager PL, Peltonen L, Stewart GJ, Hafler DA, Hauser SL, McVean G, Donnelly P, Compston A.

Nature. 2011 Aug 10;476(7359):214-9. doi: 10.1038/nature10251.

16.

Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelines.

Langevin SM, Ioannidis JP, Vineis P, Taioli E; Genetic Susceptibility to Environmental Carcinogens group (GSEC).

Pharmacogenet Genomics. 2010 Oct;20(10):586-97. doi: 10.1097/FPC.0b013e32833c3892.

17.

The Multiple Sclerosis Severity Score: associations with MC1R single nucleotide polymorphisms and host response to ultraviolet radiation.

Strange RC, Ramachandran S, Zeegers MP, Emes RD, Abraham R, Raveendran V, Boggild M, Gilford J, Hawkins CP.

Mult Scler. 2010 Sep;16(9):1109-16. doi: 10.1177/1352458510373784. Epub 2010 Jul 29.

PMID:
20670983
18.

Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.

Ramachandran S, Rajaratnam R, Smith AG, Lear JT, Strange RC.

J Am Acad Dermatol. 2009 Aug;61(2):247-51. doi: 10.1016/j.jaad.2009.03.015. Epub 2009 May 29.

PMID:
19481292
19.

Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis.

Mamutse G, Woolmore J, Pye E, Partridge J, Boggild M, Young C, Fryer A, Hoban PR, Rukin N, Alldersea J, Strange RC, Hawkins CP.

Mult Scler. 2008 Nov;14(9):1280-3. doi: 10.1177/1352458508094643. Epub 2008 Jul 24.

PMID:
18653739
20.

Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review.

Varela-Lema L, Taioli E, Ruano-Ravina A, Barros-Dios JM, Anantharaman D, Benhamou S, Boccia S, Bhisey RA, Cadoni G, Capoluongo E, Chen CJ, Foulkes W, Goloni-Bertollo EM, Hatagima A, Hayes RB, Katoh T, Koifman S, Lazarus P, Manni JJ, Mahimkar M, Morita S, Park J, Park KK, Pavarino Bertelli EC, de Souza Fonseca Ribeiro EM, Roy B, Spitz MR, Strange RC, Wei Q, Ragin CC.

Genet Med. 2008 Jun;10(6):369-84. doi: 10.1097/GIM.0b013e3181770196.

21.

Associations between timing of exposure to ultraviolet radiation, T-stage and survival in prostate cancer.

Rukin N, Blagojevic M, Luscombe CJ, Liu S, Saxby MF, Ramachandran S, Fryer AA, Jones PW, Strange RC.

Cancer Detect Prev. 2007;31(6):443-9.

PMID:
18061372
22.

Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis.

Woolmore J, Stone M, Holley S, Jenkinson P, Ike A, Jones P, Fryer A, Strange R, Stephens R, Langdon D, Hawkins C.

Mult Scler. 2008 Mar;14(2):177-82. Epub 2007 Oct 17.

PMID:
17942526
23.

What are the frequency, distribution, and functional effects of vitamin D receptor polymorphisms as related to cancer risk?

Rukin NJ, Strange RC.

Nutr Rev. 2007 Aug;65(8 Pt 2):S96-101. Review. No abstract available.

PMID:
17867380
24.

Vitamin D and oestrogen receptor polymorphisms in developmental dysplasia of the hip and primary protrusio acetabuli--a preliminary study.

Kapoor B, Dunlop C, Wynn-Jones C, Fryer AA, Strange RC, Maffulli N.

J Negat Results Biomed. 2007 Jun 28;6:7.

25.

Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis.

Holley SL, Fryer AA, Haycock JW, Grubb SE, Strange RC, Hoban PR.

Carcinogenesis. 2007 Nov;28(11):2268-73. Epub 2007 Jun 8.

PMID:
17557902
26.

Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation.

Woolmore JA, Stone M, Pye EM, Partridge JM, Boggild M, Young C, Jones PW, Fryer AA, Hawkins CP, Strange RC.

Mult Scler. 2007 Apr;13(3):369-75.

PMID:
17439906
27.

Evidence of gene gene interactions in lung carcinogenesis in a large pooled analysis.

Vineis P, Anttila S, Benhamou S, Spinola M, Hirvonen A, Kiyohara C, Garte SJ, Puntoni R, Rannug A, Strange RC, Taioli E.

Carcinogenesis. 2007 Sep;28(9):1902-5. Epub 2007 Feb 16. Review.

PMID:
17307802
28.

A comparison of sunlight exposure in men with prostate cancer and basal cell carcinoma.

Rukin NJ, Zeegers MP, Ramachandran S, Luscombe CJ, Liu S, Saxby M, Lear J, Strange RC.

Br J Cancer. 2007 Feb 12;96(3):523-8. Epub 2007 Jan 30.

30.

Sunshine is good medicine. The health benefits of ultraviolet-B induced vitamin D production.

Grant WB, Strange RC, Garland CF.

J Cosmet Dermatol. 2003 Apr;2(2):86-98.

PMID:
17156062
31.

Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review.

Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P, Cote ML, Dialyna IA, Dolzan V, Filiberti R, Garte S, Hirvonen A, Husgafvel-Pursiainen K, Imyanitov EN, Kalina I, Kang D, Kiyohara C, Kohno T, Kremers P, Lan Q, London S, Povey AC, Rannug A, Reszka E, Risch A, Romkes M, Schneider J, Seow A, Shields PG, Sobti RC, Sørensen M, Spinola M, Spitz MR, Strange RC, Stücker I, Sugimura H, To-Figueras J, Tokudome S, Yang P, Yuan JM, Warholm M, Taioli E.

Am J Epidemiol. 2006 Dec 1;164(11):1027-42. Epub 2006 Sep 25.

PMID:
17000715
32.

Prostate cancer susceptibility is mediated by interactions between exposure to ultraviolet radiation and polymorphisms in the 5' haplotype block of the vitamin D receptor gene.

Rukin NJ, Luscombe C, Moon S, Bodiwala D, Liu S, Saxby MF, Fryer AA, Alldersea J, Hoban PR, Strange RC.

Cancer Lett. 2007 Mar 18;247(2):328-35. Epub 2006 Jul 3.

PMID:
16815628
33.

Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up.

Madan V, Hoban PR, Strange RC, Fryer AA, Lear JT.

Br J Dermatol. 2006 Jul;155(1):217-8. No abstract available.

PMID:
16792784
34.

Basal cell carcinoma: genetic homogeneity in a tumour type displaying phenotypic diversity.

Hoban PR, Lear JT, Strange RC.

Eur J Hum Genet. 2006 Sep;14(9):977-8. Epub 2006 May 24. No abstract available.

35.

Genetics and risk factors for basal cell carcinoma.

Madan V, Hoban P, Strange RC, Fryer AA, Lear JT.

Br J Dermatol. 2006 May;154 Suppl 1:5-7. Review.

PMID:
16712709
36.

Associations between G/A1229, A/G3944, T/C30875, C/T48200 and C/T65013 genotypes and haplotypes in the vitamin D receptor gene, ultraviolet radiation and susceptibility to prostate cancer.

Moon S, Holley S, Bodiwala D, Luscombe CJ, French ME, Liu S, Saxby MF, Jones PW, Fryer AA, Strange RC.

Ann Hum Genet. 2006 Mar;70(Pt 2):226-36.

37.

Asthma severity and atopy: how clear is the relationship?

Carroll WD, Lenney W, Child F, Strange RC, Jones PW, Whyte MK, Primhak RA, Fryer AA.

Arch Dis Child. 2006 May;91(5):405-9. Epub 2006 Jan 27.

38.

Polymorphisms in the glutathione S-transferase mu cluster are associated with tumour progression and patient outcome in colorectal cancer.

Holley SL, Rajagopal R, Hoban PR, Deakin M, Fawole AS, Elder JB, Elder J, Smith V, Strange RC, Fryer AA.

Int J Oncol. 2006 Jan;28(1):231-6.

PMID:
16328000
39.

Effects of glutathione S-transferase M1, T1 and P1 on lung function in asthmatic families.

Carroll WD, Lenney W, Jones PW, Strange RC, Child F, Whyte MK, Primhak RA, Fryer AA.

Clin Exp Allergy. 2005 Sep;35(9):1155-61.

PMID:
16164441
40.

Glutathione S-transferase T1 polymorphisms are associated with outcome in colorectal cancer.

Rajagopal R, Deakin M, Fawole AS, Elder JB, Elder J, Smith V, Strange RC, Fryer AA.

Carcinogenesis. 2005 Dec;26(12):2157-63. Epub 2005 Jul 28.

PMID:
16051638
41.

Ultraviolet radiation, vitamin D and risk of prostate cancer and other diseases.

Moon SJ, Fryer AA, Strange RC.

Photochem Photobiol. 2005 Nov-Dec;81(6):1252-60. Review.

PMID:
16022557
42.

Polymorphism in the nuclear excision repair gene ERCC2/XPD: association between an exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma.

Lovatt T, Alldersea J, Lear JT, Hoban PR, Ramachandran S, Fryer AA, Smith AG, Strange RC.

Hum Mutat. 2005 Apr;25(4):353-9.

PMID:
15776433
43.

CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions.

Vineis P, Veglia F, Anttila S, Benhamou S, Clapper ML, Dolzan V, Ryberg D, Hirvonen A, Kremers P, Le Marchand L, Pastorelli R, Rannug A, Romkes M, Schoket B, Strange RC, Garte S, Taioli E.

Biomarkers. 2004 May-Jun;9(3):298-305.

PMID:
15764294
44.

Regional variation of airway hyperresponsiveness in children with asthma.

Carroll WD, Lenney W, Proctor A, Whyte MC, Primhak RA, Cliffe I, Jones PW, Strange RC, Fryer AA, Child F.

Respir Med. 2005 Apr;99(4):403-7.

45.

Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors.

Lovatt TJ, Lear JT, Bastrilles J, Wong C, Griffiths CE, Samarasinghe V, Roebuck J, Ramachandran S, Smith AG, Jones PW, Fryer AA, Strange RC.

J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):468-73.

PMID:
15761425
46.

Ultraviolet radiation: effects on risks of prostate cancer and other internal cancers.

Moon SJ, Fryer AA, Strange RC.

Mutat Res. 2005 Apr 1;571(1-2):207-19. Epub 2005 Jan 28.

PMID:
15748648
47.

Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma.

Holley SL, Matthias C, Jahnke V, Fryer AA, Strange RC, Hoban PR.

Oral Oncol. 2005 Feb;41(2):156-60.

PMID:
15695117
48.

Maternal glutathione S-transferase GSTP1 genotype is a specific predictor of phenotype in children with asthma.

Carroll WD, Lenney W, Child F, Strange RC, Jones PW, Fryer AA.

Pediatr Allergy Immunol. 2005 Feb;16(1):32-9.

PMID:
15693909
49.

Basal cell carcinoma: from host response and polymorphic variants to tumour suppressor genes.

Lear JT, Hoban P, Strange RC, Fryer AA.

Clin Exp Dermatol. 2005 Jan;30(1):49-55. Review.

PMID:
15663504
50.

Susceptibility to basal cell carcinoma: associations with PTCH polymorphisms.

Strange RC, El-Genidy N, Ramachandran S, Lovatt TJ, Fryer AA, Smith AG, Lear JT, Wong C, Jones PW, Ichii-Jones F, Hoban PR.

Ann Hum Genet. 2004 Nov;68(Pt 6):536-45.

Supplemental Content

Loading ...
Support Center